This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of skin of trunk
CD2_INSITU_SKIN_TRUNK_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D04
- Name in latin
- Carcinoma in situ cutis trunci
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of skin of trunk
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of skin of trunk
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 989 | 382 | 607 |
| Unadjusted period prevalence (%) | 0.21 | 0.13 | 0.27 |
| Median age at first event (years) | 76.35 | 74.81 | 77.31 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 837
- Matched controls
- 8369
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
36.2
323.0
488
311
L57.0
ICD-10 Finland
Actinic keratosis
44.7
323.0
595
435
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
4503599627370496.0
323.0
833
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
647.6
321.0
298
7
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
51.3
301.9
365
124
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
1920.1
289.0
264
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
145.1
246.9
254
25
TQW99
NOMESCO Finland
Other minor procedure on skin
37.5
240.7
313
131
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
238.2
217
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
32.8
227.6
307
145
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
32.0
200.5
271
123
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
76.0
200.0
224
40
ZXC50
NOMESCO Finland
Cryotherapy
40.1
168.7
214
71
R23.8
ICD-10 Finland
Other and unspecified skin changes
10.6
164.5
371
582
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
42.7
156.1
195
59
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
37.3
145.1
187
64
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
526.5
138.5
134
*
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
337.3
117.3
116
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
116.4
109
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
106.6
100
*
ZZR00
NOMESCO Finland
Flap of skin
106.5
102.9
111
12
S18
ICPC
Laceration/cut
5.0
102.8
562
2426
ZXC15
NOMESCO Finland
Use of photodynamic technique
51.6
96.7
116
26
ZXC20
NOMESCO Finland
Use of chemical agents
37.7
96.1
123
38
ZQZ00
NOMESCO Finland
Treatment of several skin areas
184.6
95.4
98
6
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
41.8
95.1
119
33
D06BB10
ATC
imiquimod; topical
14.4
92.8
164
139
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
92.4
89.3
98
12
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
82.7
78
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
438.0
81.4
80
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
79.4
75
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
290.4
78.9
79
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
176.5
77.5
80
5
L82
ICD-10 Finland
Seborrhoeic keratosis
5.2
75.3
275
714
XQ848
NOMESCO Finland
Dermatological photography
20.3
73.5
112
63
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
748.6
71.2
69
*
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
64.7
71.1
82
14
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
20.3
68.3
104
58
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
713.2
68.0
66
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
65.5
62
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
337.1
62.2
62
*
127
Kela drug reimbursment
Transplant complication
45.0
60.3
74
18
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
312.8
58.0
58
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
58.0
55
*
SPAT1153
SPAT
Removal of sutures
3.4
57.7
401
1779
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
585.4
56.3
55
*
S77
ICPC
Malignant neoplasm of skin
192.0
52.6
54
*
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
51.3
51.9
62
13
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
117.5
51.4
55
5
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
37.0
50.9
65
19
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
271.1
50.7
51
*
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
82.4
48.5
54
7
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
248.5
46.5
47
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
+∞
46.3
44
*
116
Kela drug reimbursment
Prostate cancer
+∞
46.3
44
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
15.0
45.5
77
56
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
127.1
45.2
48
*
Z94.0
ICD-10 Finland
Kidney transplant status
31.6
44.6
59
20
Z2221
NOMESCO Finland
Medical doctor
3.1
44.1
317
1371
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
10.1
43.5
89
97
ZXE10
NOMESCO Finland
More than one and less than three hours
2.9
43.2
389
1944
115
Kela drug reimbursment
Breast cancer
+∞
43.1
41
*
130
Kela drug reimbursment
Malignant tumour
+∞
43.1
41
*
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
58.9
42.9
50
9
XQ845
NOMESCO Finland
Dermatoscopy
23.4
42.4
61
28
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
41.4
489
2858
JN4BD
NOMESCO Finland
Extensive body CT
6.3
41.0
116
209
L04AD01
ATC
ciclosporin; systemic
21.8
40.2
59
29
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
92.8
40.2
44
5
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
40.1
270
1100
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
38.8
37
*
WF002
NOMESCO Finland
Radical radiotherapy
75.2
38.3
43
6
E0000UV
ATC
NA
2.7
38.0
393
2088
L04AA06
ATC
mycophenolic acid; systemic
21.3
37.9
56
28
Z3231
NOMESCO Finland
Registered nurse
2.8
37.8
316
1476
DAB00
NOMESCO Finland
Excision of lesion of auricle
36.3
37.6
48
14
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
51.4
37.0
44
9
S29
ICPC
Skin symptom/complaint other
3.3
36.6
219
812
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
372.5
36.3
36
*
WX110
NOMESCO Finland
Local anesthesy
2.6
36.2
546
3540
S21
ICPC
Skin texture symptom/complaint
3.7
36.0
176
557
ZXE00
NOMESCO Finland
One hour or less
2.5
34.9
394
2167
ZXD10
NOMESCO Finland
Scheduled procedure
2.5
34.6
397
2196
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.9
34.0
100
188
DHB00
NOMESCO Finland
Excision of lesion of external nose
121.6
32.9
35
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
51.0
32.8
39
8
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
32.5
31
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
32.5
31
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
16.2
32.1
52
34
L02AE02
ATC
leuprorelin; implant, parenteral
171.5
31.9
33
*
R4110
NOMESCO Finland
Physiotherapy
2.7
31.9
282
1331
TQW80
NOMESCO Finland
Local dermatologic skincare
9.8
31.7
65
71
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.7
30.3
80
130
L04AA01
ATC
[U] ciclosporin; systemic
16.2
30.3
49
32
D06BX02
ATC
ingenol mebutate; topical
14.2
29.9
51
38
A98
ICPC
Health maint/preventive medicine
3.7
29.7
775
6455
HAB40
NOMESCO Finland
Wedge excision of mammary gland
52.0
29.6
35
7
J01DB01
ATC
cefalexin; oral
2.6
29.5
676
5159
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.0
29.5
202
810
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
29.3
28
*
HAC20
NOMESCO Finland
Total mastectomy
301.8
29.0
29
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
14.9
28.7
48
34
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
37.5
28.6
36
10
JN4AD
NOMESCO Finland
Body CT examination
6.4
28.5
78
133
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
27.9
241
1108
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
10.8
27.8
54
53
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
39.3
27.3
34
9
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
+∞
27.2
26
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.7
27.0
64
89
WX002
NOMESCO Finland
Sedation and analgesia
2.6
27.0
236
1091
DAB10
NOMESCO Finland
Partial excision of auricle
279.5
26.9
27
*
HA1AA
NOMESCO Finland
X-ray mammography
8.5
26.6
59
74
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
96.5
25.8
28
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
96.5
25.8
28
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
139.3
25.7
27
*
S82
ICPC
Naevus/mole
3.4
25.3
136
455
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.3
25.1
80
165
L04AX01
ATC
azathioprine; systemic
6.0
25.0
71
127
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
24.1
23
*
N02BE01
ATC
paracetamol; systemic, rectal
2.7
23.7
730
6012
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
7.4
23.5
57
82
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
23.2
145
539
A12AA04
ATC
calcium carbonate; oral
10.1
23.0
46
48
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
23.0
22
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
23.0
22
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
23.0
22
*
A04AA02
ATC
granisetron; systemic, transdermal
123.3
22.7
24
*
Y77
ICPC
Malignant neoplasm prostate
123.3
22.7
24
*
TK800
NOMESCO Finland
Hemodialysis
7.9
22.2
51
68
ZXA00
NOMESCO Finland
Right side
2.2
22.1
292
1632
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
8.3
22.0
49
62
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
22.0
21
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
22.0
21
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
22.0
21
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
22.0
21
*
B07.9
ICD-10 Finland
Verruca simplex
7.1
21.9
54
80
ZXA05
NOMESCO Finland
Left side
2.2
21.8
290
1624
WF049
NOMESCO Finland
Radiotherapy of metastasis
225.5
21.7
22
*
L03AA02
ATC
filgrastim; parenteral
225.5
21.7
22
*
ZZA00
NOMESCO Finland
Split skin graft
6.4
21.1
56
92
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
20.9
20
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
20.9
20
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
20.9
20
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
215.0
20.7
21
*
137
Kela drug reimbursment
Uraemia requiring dialysis
15.6
20.3
33
22
D07AB08
ATC
desonide; topical
3.0
20.3
128
477
H02AB02
ATC
dexamethasone; systemic
11.0
20.1
38
36
ZZA50
NOMESCO Finland
Full thickness skin graft
59.0
20.0
23
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.9
19.9
50
76
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
19.9
19
*
Z3226
NOMESCO Finland
Physiotherapist
2.4
19.7
189
898
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
19.6
159
690
A11CC03
ATC
alfacalcidol; systemic
6.4
19.2
51
84
D07AC01
ATC
betamethasone; topical
2.0
19.1
320
1953
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.5
19.0
39
43
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
18.8
18
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
18.8
18
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
18.8
18
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
18.8
18
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.9
18.7
122
461
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
18.7
149
640
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
194.1
18.6
19
*
L02BG04
ATC
letrozole; oral
194.1
18.6
19
*
TQW40
NOMESCO Finland
Remowal of suture of skin
4.0
18.6
78
212
ZX120
NOMESCO Finland
Intravenous
3.4
18.5
94
299
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
22.3
18.3
26
12
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
33.7
18.0
23
7
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
53.7
18.0
21
*
UKC02
NOMESCO Finland
Cystoscopy
2.3
18.0
193
963
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.0
17.9
74
199
A02BC02
ATC
pantoprazole; systemic
1.9
17.8
548
4151
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
68.1
17.8
20
*
C44.20
ICD-10 Finland
Malignant tumor of the skin of the outer ear and of the outer ear canal without histology
+∞
17.8
17
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
17.8
17
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.0
17.6
109
400
XX3DW
NOMESCO Finland
Time consuming IT work
4.0
17.6
73
197
WZC30
NOMESCO Finland
Teaching
3.1
17.5
103
364
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
17.5
277
1640
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
24.6
17.4
24
10
B03XA01
ATC
erythropoietin; parenteral
17.8
17.0
26
15
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
17.0
176
861
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
16.9
307
1908
L02BB03
ATC
bicalutamide; oral
+∞
16.7
16
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
16.7
16
*
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
16.7
16
*
7151
FHL
Kidney transplantation
91.9
16.6
18
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.7
16.6
57
128
ZXC10
NOMESCO Finland
Use of laser
7.8
16.6
38
51
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
173.2
16.5
17
*
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
173.2
16.5
17
*
D03.5
ICD-10 Finland
Melanoma in situ of trunk
173.2
16.5
17
*
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
173.2
16.5
17
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.7
16.5
75
219
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
16.4
87
286
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.1
16.3
211
1141
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
30.7
16.2
21
7
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
12.0
16.1
29
25
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
9.7
16.0
32
34
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.7
15.8
40
62
J01MA02
ATC
ciprofloxacin; systemic
1.9
15.7
357
2391
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
+∞
15.7
15
*
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
+∞
15.7
15
*
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
+∞
15.7
15
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
15.7
15
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
162.8
15.5
16
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
162.8
15.5
16
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
29.2
15.2
20
7
ZX112
NOMESCO Finland
Subcutaneous
23.9
15.2
21
9
L57.9
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation, unspecified
57.7
14.8
17
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
25.5
14.7
20
8
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
152.5
14.5
15
*
L02BA01
ATC
tamoxifen; oral
152.5
14.5
15
*
J01MA12
ATC
levofloxacin; systemic
2.1
14.4
187
1009
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
9.3
14.3
29
32
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.5
14.2
42
80
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
43.3
14.1
17
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.6
14.1
30
36
M04AA01
ATC
allopurinol; systemic
2.1
14.0
177
943
B01AB05
ATC
enoxaparin; parenteral
1.9
14.0
256
1572
J01CA04
ATC
amoxicillin; systemic
1.8
13.8
609
4968
B01AB10
ATC
tinzaparin; parenteral
3.7
13.7
61
175
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
13.6
13
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
13.6
13
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
13.6
13
*
ZXD05
NOMESCO Finland
Urgent procedure
1.8
13.5
277
1766
Z51.5
ICD-10 Finland
Palliative care
4.7
13.5
46
103
B03XA02
ATC
darbepoetin alfa; parenteral
7.4
13.3
31
43
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.5
13.3
39
74
D07AB02
ATC
hydrocortisone butyrate; topical
1.9
13.3
243
1488
205
Kela drug reimbursment
Chronic hypertension
1.8
13.2
357
2490
A04AA01
ATC
ondansetron; systemic, rectal
6.4
13.2
34
55
Z2446
NOMESCO Finland
Social worker
3.3
13.1
66
209
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
28.9
13.0
17
6
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.3
13.0
34
56
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.5
12.8
105
454
B05DA
ATC
Isotonic solutions
12.5
12.7
22
18
S15
ICPC
Foreign body in skin
3.2
12.6
68
227
ZX070
NOMESCO Finland
Intensity modified radiotherapy
70.9
12.6
14
*
CBB30
NOMESCO Finland
Excision of lesion of eyelid
4.6
12.6
43
97
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
12.5
12
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
12.5
12
*
C44.59
ICD-10 Finland
Malignant tumor of the skin on the trunk other or unspecified histology
+∞
12.5
12
*
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
12.5
12
*
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
12.5
12
*
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
7.8
12.5
28
37
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
131.8
12.5
13
*
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.9
12.5
199
1158
QXA05
NOMESCO Finland
Skin division, unspecified location
38.1
12.2
15
*
D04
ICD-10 Finland
Carcinoma in situ of skin
38.1
12.2
15
*
E000001
ATC
NA
2.0
12.1
176
986
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
12.1
206
1224
XKD00
NOMESCO Finland
Uroflowmetry
2.0
12.0
177
996
Z3229
NOMESCO Finland
Other healthcare associate professional
2.4
12.0
103
456
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.7
11.9
84
331
S08
ICPC
Skin colour change
3.2
11.9
62
202
UJF32
NOMESCO Finland
Coloscopy
1.9
11.9
226
1393
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
47.3
11.9
14
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
11.8
354
2519
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
11.8
180
1026
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.8
11.7
232
1453
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
11.6
286
1917
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.7
11.6
50
141
P01AB01
ATC
metronidazole; oral, rectal
1.8
11.6
276
1831
C44.82
ICD-10 Finland
Overall spinocellular carcinoma of the skin
+∞
11.5
11
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
121.6
11.4
12
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
11.4
359
2583
N02AX02
ATC
tramadol; systemic, rectal
1.7
11.4
353
2529
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.1
11.3
139
726
D02AE01
ATC
carbamide; topical
2.9
11.3
69
250
S26
ICPC
Fear of cancer of skin
9.8
11.3
22
23
Z94.1
ICD-10 Finland
Heart transplant status
35.5
11.3
14
*
N18.0
ICD-10 Finland
End-stage renal disease
6.9
11.2
27
40
S97
ICPC
Chronic ulcer skin
2.7
11.2
76
294
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
8.7
11.1
23
27
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
6.4
11.0
28
45
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.1
11.0
62
213
H02AB04
ATC
methylprednisolone; systemic
2.1
10.9
138
729
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
3.5
10.8
50
149
G04CA02
ATC
tamsulosin; oral
1.7
10.8
287
1956
J05AB01
ATC
aciclovir; systemic
2.0
10.8
161
909
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
10.7
179
1050
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
10.6
227
1450
GD1AD
NOMESCO Finland
Thorax CT examination
3.7
10.5
45
127
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
111.3
10.4
11
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
10.4
10
*
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
+∞
10.4
10
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
10.4
10
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
10.4
10
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
10.4
10
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
10.4
10
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
10.4
10
*
V03AE01
ATC
polystyrene sulfonate; oral
6.9
10.4
25
37
N02AA05
ATC
oxycodone; systemic
2.1
10.4
126
652
R50.9
ICD-10 Finland
Fever, unspecified
2.2
10.3
112
555
L01BB01
ATC
NA
19.1
10.3
15
8
TQW40
SPAT
NA
4.3
10.3
37
89
V03AE02
ATC
sevelamer; oral
23.7
10.3
14
6
C02CA01
ATC
prazosin; oral
4.1
10.2
39
99
H02AB07
ATC
prednisone; oral
2.0
10.2
133
711
QBE99
SPAT
NA
13.3
10.2
17
13
WX320
NOMESCO Finland
Spinalanesthesy
1.8
10.0
208
1312
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.7
10.0
43
121
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
14.8
10.0
16
11
J05AB11
ATC
valaciclovir; oral
2.2
9.9
106
520
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
8.3
9.9
21
26
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.8
9.7
31
66
L03
ICPC
Low back symptom/complaint
1.8
9.7
188
1160
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
55.6
9.7
11
*
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
9.6
390
2960
C03CA01
ATC
furosemide; systemic
1.6
9.5
360
2683
XJH00
NOMESCO Finland
Transanal ultrasonography
2.5
9.5
77
332
A46
ICD-10 Finland
Erysipelas
1.9
9.5
147
837
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.6
9.4
338
2482
C02EA02
ATC
NA
2.4
9.4
77
333
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
101.1
9.4
10
*
WF004
NOMESCO Finland
Palliative radiotherapy
101.1
9.4
10
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
6.3
9.4
24
39
A02BC01
ATC
omeprazole; systemic
1.7
9.4
249
1683
Z94.4
ICD-10 Finland
Liver transplant status
30.4
9.4
12
*
Z71.8
ICD-10 Finland
Other specified counselling
1.8
9.4
170
1021
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
9.4
138
771
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
9.4
9
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
9.4
9
*
EAA30
NOMESCO Finland
Partial excision of lower lip
+∞
9.4
9
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
9.4
9
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
+∞
9.4
9
*
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
+∞
9.4
9
*
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
+∞
9.4
9
*
C44.40
ICD-10 Finland
Malignant tumor of the skin of the scalp and neck without histology
+∞
9.4
9
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
9.4
9
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
22.0
9.4
13
6
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
3.6
9.3
40
114
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
9.2
90
423
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.1
9.2
102
510
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
9.2
442
3485
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.8
9.2
22
33
WX402
NOMESCO Finland
General anaesthesia
2.2
9.1
98
483
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
15.8
9.0
14
9
L56.8
ICD-10 Finland
Other specified acute skin changes due to ultraviolet radiation
37.1
9.0
11
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
9.0
131
729
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
18.8
8.9
13
7
J01CE02
ATC
phenoxymethylpenicillin; oral
1.6
8.9
473
3805
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
24.3
8.9
12
5
L17
ICPC
Foot/toe symptom/complaint
1.7
8.8
212
1392
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
8.8
230
1546
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.6
8.7
352
2644
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
50.5
8.7
10
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
50.5
8.7
10
*
L01AA02
ATC
chlorambucil; oral
50.5
8.7
10
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.4
8.7
74
327
H02AB06
ATC
prednisolone; systemic
1.6
8.6
385
2961
ZXA10
NOMESCO Finland
Bilateral
1.8
8.6
179
1123
QBA10
NOMESCO Finland
Incision of skin of trunk
11.7
8.6
15
13
CBA10
NOMESCO Finland
Biopsy of eyelid
10.2
8.5
16
16
J02AC01
ATC
fluconazole; systemic
1.7
8.5
226
1524
ZY010
NOMESCO Finland
Hospital outpatient
4.1
8.5
32
81
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.1
8.5
46
156
Z02.4
ICD-10 Finland
Examination for driving licence
1.6
8.5
255
1778
XW000
NOMESCO Finland
Bone marrow biopsy
3.5
8.5
38
112
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.5
8.5
38
112
E000002
ATC
NA
2.2
8.5
83
392
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.8
8.4
53
197
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
90.9
8.4
9
*
C44.70
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including the hip without histology
90.9
8.4
9
*
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
90.9
8.4
9
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
3.9
8.4
33
87
J01FF01
ATC
clindamycin; systemic
1.7
8.4
206
1358
L02BG03
ATC
anastrozole; oral
+∞
8.3
8
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
8.3
8
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
8.3
8
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
8.3
8
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.3
8
*
TQW20
NOMESCO Finland
Tatoe
+∞
8.3
8
*
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
8.3
8
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
8.3
8
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
8.3
8
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
8.3
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.3
8
*
Z49.2
ICD-10 Finland
Other dialysis
9.6
8.3
16
17
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.5
8.3
63
262
ZXC96
NOMESCO Finland
Robot assisted procedure
14.6
8.2
13
9
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
8.2
60
245
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.5
8.2
377
2913
C07AB07
ATC
bisoprolol; oral
1.5
8.1
476
3878
QDA50
NOMESCO Finland
Cryotherapy of skin of lower limb
33.7
8.1
10
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
8.1
81
388
B05DB
ATC
Hypertonic solutions
10.2
8.0
15
15
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
10.2
8.0
15
15
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
22.3
8.0
11
5
D02AX
ATC
Other emollients and protectives
3.7
8.0
33
91
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.8
8.0
32
86
WX892
NOMESCO Finland
Monitored bed care
2.2
7.9
77
362
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.9
7.9
46
163
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
5.0
7.9
24
49
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.7
7.9
54
211
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
7.9
570
4857
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
7.9
336
2542
R60.0
ICD-10 Finland
Localized oedema
2.0
7.9
108
588
D07AA02
ATC
hydrocortisone; topical
2.0
7.9
102
542
N40
ICD-10 Finland
Hyperplasia of prostate
1.6
7.9
264
1884
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
7.9
92
470
XCK10
NOMESCO Finland
Photography of fundus of eye
1.9
7.8
113
626
S79
ICPC
Neoplasm skin benign/unspecified
4.9
7.8
24
50
U02
ICPC
Urinary frequency/urgency
2.0
7.8
109
595
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
7.0
7.8
18
26
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.8
7.8
153
942
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
7.8
272
1965
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
7.7
229
1585
WXQ99
NOMESCO Finland
Other light therapy
45.4
7.7
9
*
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
45.4
7.7
9
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
7.7
107
587
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.3
7.7
70
319
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.7
7.7
172
1102
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
7.6
59
249
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
25.2
7.6
10
*
1XC02
NOMESCO Finland
NA
25.2
7.6
10
*
SPAT1211
SPAT
Application of soft bandage
2.1
7.6
84
421
R31
ICD-10 Finland
Unspecified haematuria
2.0
7.6
102
552
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
5.5
7.6
21
39
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.0
7.6
15
17
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
7.6
180
1173
KCD02
NOMESCO Finland
Transurethral resection of bladder
10.1
7.5
14
14
K02.1
ICD-10 Finland
Caries of dentine
1.5
7.5
338
2582
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
7.2
7.5
17
24
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
7.5
213
1459
K05.30
ICD-10 Finland
Periodontitis complex
2.0
7.5
93
486
C08CA13
ATC
lercanidipine; oral
1.8
7.5
141
857
R06.0
ICD-10 Finland
Dyspnoea
1.6
7.4
234
1642
RS220
NOMESCO Finland
NA
6.5
7.4
18
28
A79
ICPC
Malignancy NOS
80.7
7.4
8
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
80.7
7.4
8
*
ZZS00
NOMESCO Finland
Rotation flap
80.7
7.4
8
*
TDA10
NOMESCO Finland
Needle biopsy of auricle or external auditory canal
80.7
7.4
8
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.2
7.4
71
332
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
7.4
93
489
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
7.4
167
1072
XF404
NOMESCO Finland
Ambulatory ECG
1.9
7.4
103
565
S04
ICPC
Lump/swelling localized
2.3
7.4
66
300
-1
NOMESCO Finland
NA
1.6
7.3
195
1308
U13
ICPC
Bladder symptom/complaint other
3.2
7.3
36
115
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
7.3
331
2527
Z49.0
ICD-10 Finland
Preparatory care for dialysis
6.9
7.3
17
25
WW200
NOMESCO Finland
Immunization
3.9
7.3
28
73
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
+∞
7.3
7
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
7.3
7
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
7.3
7
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
7.3
7
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
7.3
7
*
8070/3-C44.7
ICD-O-3
Squamous cell carcinoma, NOS, of skin of lower limb and hip
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
X76
ICPC
Malignant neoplasm breast female
+∞
7.3
7
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
58200
ICD-8 Finland
Chronic nephritis, Cum uraemia
+∞
7.3
7
*
8091/3-C44.9
ICD-O-3
Superficial basal cell carcinoma of skin, NOS
+∞
7.3
7
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
7.3
7
*
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
+∞
7.3
7
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
7.3
7
*
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
3.8
7.2
29
79
RD210
NOMESCO Finland
NA
7.4
7.2
16
22
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.2
7.2
74
356
JN4CD
NOMESCO Finland
Very extensive body CT
4.5
7.2
24
55
EBA10
NOMESCO Finland
Surgical removal of tooth
2.3
7.2
64
288
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.9
7.2
42
151
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
7.2
137
837
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
30.3
7.2
9
*
4056
NOMESCO Finland
NA
30.3
7.2
9
*
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
30.3
7.2
9
*
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
3.5
7.2
31
90
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.9
7.1
113
645
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
20.2
7.1
10
5
L12
ICPC
Hand/finger symptom/complaint
1.9
7.1
106
594
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
7.1
298
2231
R06AE07
ATC
cetirizine; oral
1.5
7.1
275
2025
H02AB09
ATC
hydrocortisone; systemic
4.4
7.1
24
56
D01AE16
ATC
amorolfine; topical
1.9
7.1
109
619
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.2
7.0
35
113
Z01.9
ICD-10 Finland
Special examination, unspecified
2.6
7.0
49
195
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
7.0
254
1838
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
4.3
7.0
24
57
SPAT1325
SPAT
Vaccination
1.5
7.0
336
2592
J01FA10
ATC
azithromycin; systemic
1.5
7.0
336
2593
WW500
NOMESCO Finland
Blood transfusion
3.6
6.9
29
82
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.9
6.9
40
142
212
Kela drug reimbursment
Gout
3.4
6.9
32
98
-54
ICPC
Repair/fix-suture/cast/prosth device
3.4
6.9
32
98
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
6.8
6.8
16
24
N03AX16
ATC
pregabalin; oral
1.6
6.8
180
1201
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.7
6.8
28
78
EB1AA
SPAT
NA
3.1
6.8
35
116
D07AC13
ATC
mometasone; topical
1.6
6.7
225
1595
M79.6
ICD-10 Finland
Pain in limb
1.5
6.7
263
1936
XF402
NOMESCO Finland
ECG with work load test
1.8
6.7
118
700
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
22.7
6.7
9
*
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
5.2
6.7
19
37
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
5.2
6.7
19
37
3AC01
NOMESCO Finland
NA
6.0
6.6
17
29
I78.1
ICD-10 Finland
Naevus, non-neoplastic
4.1
6.6
24
60
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
12.4
6.6
11
9
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
6.6
239
1725
C08CA01
ATC
amlodipine; oral
1.5
6.6
352
2766
R23.4
ICD-10 Finland
Changes in skin texture
8.8
6.6
13
15
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
8.8
6.6
13
15
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.7
6.5
26
71
N03AX12
ATC
gabapentin; oral
1.8
6.5
120
725
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.6
6.5
21
47
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
3.6
6.4
27
77
7531A
ICD-9 Finland
Congenital anomalies of urinary system, Cystic kidney disease
70.3
6.4
7
*
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
70.3
6.4
7
*
K03.64
ICD-10 Finland
Dental calculus supragingival
1.7
6.4
147
943
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
6.4
153
994
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
14.4
6.4
10
7
L57.8
ICD-10 Finland
Other skin changes due to chronic exposure to nonionizing radiation
14.4
6.4
10
7
U06
ICPC
Haematuria
3.2
6.4
31
99
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
8.2
6.3
13
16
R4190
NOMESCO Finland
Nutritional therapy
5.6
6.3
17
31
H05BX01
ATC
cinacalcet; oral
9.3
6.3
12
13
V03AE03
ATC
lanthanum carbonate; oral
18.2
6.3
9
5
ZZR10
NOMESCO Finland
Flap of skin and muscle
18.2
6.3
9
5
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
6.3
166
1109
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
+∞
6.3
6
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
+∞
6.3
6
*
C44.00
ICD-10 Finland
Malignant tumor of the lip skin without histology
+∞
6.3
6
*
8543/3-C50.9
ICD-O-3
Paget disease and intraductal carcinoma of breast of breast, NOS
+∞
6.3
6
*
C44.99
ICD-10 Finland
Unspecified localization of malignant tumor in skin other or unspecified histology
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
6.3
6
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
6.3
6
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
6.3
6
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
6.3
6
*
L04AA05
ATC
[U] tacrolimus; systemic
+∞
6.3
6
*
C44.5
ICD-10 Finland
Malignant neoplasm: Skin of trunk
+∞
6.3
6
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
6.3
6
*
C44.01
ICD-10 Finland
Basocellular carcinoma of the lip skin
+∞
6.3
6
*
D01BA02
ATC
terbinafine; oral; topical
1.6
6.3
195
1357
KMAK
NOMESCO Finland
NA
1.5
6.3
307
2363
WX882
NOMESCO Finland
High dependency care
3.1
6.2
31
101
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
26.9
6.2
8
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
7.1
6.2
14
20
G04BD12
ATC
mirabegron; oral
1.8
6.2
99
570
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.1
6.2
70
354
H91.1
ICD-10 Finland
Presbycusis
2.0
6.2
80
426
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.7
6.2
130
816
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
6.2
178
1214
R02
ICPC
Shortness of breath/dyspnoea
1.8
6.2
107
634
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.3
6.2
13
417
N05AX08
ATC
risperidone; systemic
0.4
6.1
18
494
K50.0
ICD-10 Finland
Crohn disease of small intestine
7.7
6.1
13
17
M05BA04
ATC
alendronic acid; oral
1.9
6.1
93
527
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
3.8
6.1
24
65
S19
ICPC
Skin injury other
2.6
6.1
43
172
A02BC05
ATC
esomeprazole; systemic
1.5
6.1
304
2347
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
12.6
6.1
10
8
R06AX27
ATC
desloratadine; oral
1.7
6.1
138
884
H26.4
ICD-10 Finland
After-cataract
1.8
6.1
111
667
-62
ICPC
Administrative procedure
2.9
6.1
33
115
VALMI
NOMESCO Finland
NA
1.7
6.0
139
892
40199
ICD-8 Finland
Essential benign hypertension
2.9
6.0
35
126
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
448
476
16.38
307.65
2.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
790
2090
14.82
307.65
5.1
1.7
—
—
—
0
0
(4035726)
205
194
13.07
195.03
1.6
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
165
277
6.95
97.18
1.4
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
479
2387
2.95
60.44
9.1
5.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
655
3922
2.98
57.63
12.1
5.6
e9/l
4.2
4.6
4.55
579
3347
(3024561) Albumin [Mass/volume] in Serum or Plasma
598
3444
2.86
56.04
6.8
3.6
g/l
34.1
34.7
1.45
554
3139
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
828
5716
3.76
55.81
11.3
5.2
u/l
80.6
78.4
0.75
781
5219
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
71
87
8.71
54.47
6.8
4.4
iu/ml
392.8
157.4
—
16
9
(3018418) pH of Serum or Plasma
463
2376
2.78
53.62
7.0
3.2
ph
7.4
7.4
0.33
84
406
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
663
4089
2.89
53.45
10.5
5.5
mmol/l
1.2
1.2
1.18
546
3433
(3002582) Erythrocytes [#/volume] in Urine
472
2463
2.75
52.65
5.0
3.2
e6/l
38.1
97.9
1.41
371
1913
(3018095) Leukocytes [#/volume] in Urine
515
2813
2.73
52.39
5.8
3.7
e6/l
97.9
112.0
0.18
380
2036
(3030467) Casts [#/volume] in Urine by Automated count
441
2237
2.75
51.82
4.9
3.1
e6/l
0.4
0.5
0.55
339
1705
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
618
3717
2.77
51.57
9.3
5.1
mmol/l
1.2
1.2
2.35
559
3259
(3022096) Basophils/100 leukocytes in Blood
558
3191
2.72
51.49
9.7
5.0
%
0.6
0.6
0.90
526
2917
(3013115) Eosinophils [#/volume] in Blood
611
3658
2.75
51.39
9.4
4.9
e9/l
0.2
0.2
0.62
534
3122
(3033658) Prothrombin time (PT) actual/Normal
376
1764
2.83
51.33
6.0
3.5
%
80.8
80.1
0.19
368
1713
(3001604) Monocytes [#/volume] in Blood
595
3525
2.73
50.94
9.1
4.8
e9/l
0.7
0.6
0.76
516
2968
(3006315) Basophils [#/volume] in Blood
596
3544
2.72
50.48
9.1
4.8
e9/l
0.0
0.0
0.09
520
2994
(3006504) Eosinophils/100 leukocytes in Blood
566
3286
2.69
50.24
9.7
5.0
%
2.7
2.9
1.68
529
2999
(3019198) Lymphocytes [#/volume] in Blood
601
3599
2.71
50.01
9.2
4.9
e9/l
2.7
1.8
1.53
530
3090
(3019069) Monocytes/100 leukocytes in Blood
567
3300
2.68
49.98
10.0
5.2
%
9.4
9.0
2.20
532
3020
(3002030) Lymphocytes/100 leukocytes in Blood
572
3350
2.68
49.68
9.8
5.2
%
26.3
25.5
0.78
538
3042
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
522
2924
2.66
49.66
5.4
3.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
567
3317
2.66
49.19
9.2
5.0
%
58.1
59.2
1.12
534
3038
(36304419) Bacteria [Presence] in Urine
424
2154
2.70
49.05
4.9
3.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
352
1646
2.77
47.75
8.6
4.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
264
1063
3.02
47.29
10.1
4.6
mmol/l
1.0
1.0
0.17
251
963
(3015377) Calcium [Moles/volume] in Serum or Plasma
481
2642
2.60
46.87
3.6
2.1
mmol/l
2.4
2.3
0.71
414
2137
(3000850) Epithelial cells [#/volume] in Urine
361
1747
2.68
45.34
3.8
2.4
e6/l
3.8
4.7
0.72
316
1517
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
228
865
3.13
45.13
5.0
2.6
u/l
240.6
241.8
0.06
219
793
(3021589) Normoblasts [#/volume] in Blood
528
3111
2.50
43.21
14.8
9.0
e9/l
0.0
0.0
0.74
431
2510
(3012095) Magnesium [Moles/volume] in Serum or Plasma
266
1132
2.85
42.55
3.9
2.3
mmol/l
0.8
0.8
1.31
246
1028
(3031040) Bacteria [#/volume] in Urine by Automated count
748
5211
2.79
42.52
6.8
4.9
e6/l
1820.3
2893.1
0.24
13
100
(3026782) Osmolality of Urine
339
1643
2.62
41.87
3.9
2.7
mosm/kgh2o
536.6
550.2
0.63
294
1365
(3001122) Ferritin [Mass/volume] in Serum or Plasma
509
2993
2.44
41.23
3.8
2.8
ug/l
149.6
146.2
0.12
454
2679
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
520
3115
2.41
40.02
2.7
2.2
nmol/l
83.3
79.5
2.15
461
2634
(3026493) Urate [Moles/volume] in Serum or Plasma
393
2098
2.45
38.94
4.5
2.6
umol/l
8769.9
9482.9
0.07
331
1744
(3002385) Erythrocyte distribution width [Ratio]
778
5663
2.75
38.06
33.6
18.8
%
14.2
13.9
10.09
766
5509
(3020779) Urea [Moles/volume] in Serum or Plasma
195
743
3.02
37.79
11.9
5.4
mmol/l
12.7
12.0
0.56
183
693
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
586
3762
2.37
37.64
8.1
3.6
umol/l
12.3
12.5
0.17
550
3498
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
912
7286
4.23
37.15
28.0
15.7
mg/l
27.7
26.8
0.36
783
5871
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
867
6741
3.32
36.33
26.9
14.8
ml/min/173m2
64.7
69.9
10.43
757
5409
(3004789) Transferrin [Mass/volume] in Serum or Plasma
264
1210
2.61
35.78
3.6
2.4
g/l
2.3
2.2
0.19
240
1100
(3023368) Bacteria identified in Blood by Culture
428
2447
2.32
35.49
6.0
4.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
405
2271
2.33
35.05
2.6
2.3
mg/l
3.2
3.0
1.19
344
1885
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
253
1147
2.62
34.97
3.8
2.5
%
20.0
22.2
2.08
223
952
(3044640) Blood type and Crossmatch panel - Blood
394
2187
2.33
34.88
3.1
2.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
933
7679
4.80
33.95
16.5
9.5
u/l
23.3
24.0
0.74
894
7256
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
135
439
3.40
33.94
2.8
1.3
ug/l
12.2
4.2
0.65
109
328
(3037467) Urinalysis macro (dipstick) panel - Urine
734
5339
2.45
33.42
6.7
4.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
940
7803
5.13
33.23
33.3
19.6
mmol/l
4.0
4.0
0.05
918
7552
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
269
1285
2.50
33.11
4.0
2.9
e6/l
1.8
2.5
0.71
145
709
(3019550) Sodium [Moles/volume] in Serum or Plasma
939
7793
5.05
33.10
32.5
19.5
mmol/l
139.3
139.7
3.12
921
7553
(3027945) Reticulocytes/100 erythrocytes in Blood
247
1141
2.55
32.59
2.9
2.0
%
1.7
1.7
0.00
211
978
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
581
3858
2.23
32.49
2.5
2.1
pmol/l
96.2
92.2
1.07
293
1960
(3032080) INR in Blood by Coagulation assay
554
3611
2.21
32.44
14.1
12.2
inr
1.3
1.5
3.29
147
995
(3007461) Platelets [#/volume] in Blood
946
7918
5.48
32.40
39.9
22.8
e9/l
226.2
235.8
4.48
919
7627
(3013707) Erythrocyte sedimentation rate by Westergren method
753
5574
2.47
32.39
5.4
4.2
mm/h
15.5
14.3
1.14
678
5048
(3024731) MCV [Entitic volume]
946
7919
5.48
32.38
39.7
22.7
fl
92.6
91.9
3.81
934
7727
(3035941) MCH [Entitic mass]
946
7919
5.48
32.38
39.7
22.7
pg
30.6
30.5
0.51
934
7728
(3026361) Erythrocytes [#/volume] in Blood
946
7920
5.47
32.35
39.9
22.8
e12/l
4.3
4.4
6.64
913
7590
(3000963) Hemoglobin [Mass/volume] in Blood
946
7920
5.47
32.35
40.0
22.9
g/l
130.1
133.4
8.24
935
7727
(3010813) Leukocytes [#/volume] in Blood
946
7921
5.47
32.32
39.9
22.8
e9/l
7.4
7.0
1.57
912
7592
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
177
708
2.83
30.98
5.5
3.7
ng/l
127.2
98.4
1.79
157
595
(3022948) Iron [Moles/volume] in Serum or Plasma
271
1339
2.41
30.68
3.7
2.4
umol/l
11.3
12.3
1.68
252
1203
(3009542) Hematocrit [Volume Fraction] of Blood
797
6136
2.54
30.03
30.6
17.6
%
39.1
38.3
2.19
519
3544
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
848
6729
2.83
29.93
5.3
4.6
mu/l
2.0
2.0
0.25
751
5942
(40761511) CBC panel - Blood by Automated count
902
7429
3.43
29.13
24.6
15.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
292
1530
2.29
28.59
2.4
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
152
591
2.86
27.90
2.5
1.8
g/l
0.2
0.2
2.10
143
528
(3042936) Bacteria identified in Isolate by Culture
232
1111
2.42
27.86
2.2
1.9
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
97
289
3.61
27.76
2.6
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
717
5374
2.22
27.11
5.3
4.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
267
1377
2.29
26.93
3.9
2.8
e6/l
0.8
1.5
1.60
145
796
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
887
7330
3.04
26.57
6.0
5.6
mmol/l
2.3
2.5
7.83
778
6552
(3007853) Bacteria identified in Skin by Aerobe culture
194
878
2.50
26.21
2.0
1.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
149
593
2.78
26.09
2.9
2.1
u/l
34.6
33.1
0.21
123
473
(3013826) Glucose [Moles/volume] in Serum or Plasma
652
4749
2.09
26.02
6.3
4.4
mmol/l
6.7
7.0
2.82
624
4447
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
859
7018
2.70
25.64
7.8
7.0
mmol/mol
41.2
41.6
0.51
772
6355
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
491
3256
2.01
25.15
4.7
3.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
482
3190
2.00
24.68
2.5
2.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
95
308
3.31
23.78
2.8
2.7
u/ml
0.4
0.4
0.54
58
188
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
858
7102
2.57
23.15
5.2
4.9
mmol/l
4.2
4.3
4.97
758
6367
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
217
1087
2.28
23.07
2.0
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
872
7283
2.67
22.89
6.1
5.2
mmol/l
6.1
6.2
1.26
754
6426
(3021960) Folate [Moles/volume] in Serum or Plasma
377
2336
1.99
22.86
1.8
1.6
nmol/l
22.3
20.0
0.96
316
1934
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
297
1691
2.08
22.78
3.0
2.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
116
437
2.87
22.40
1.9
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
134
547
2.68
22.19
1.7
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
215
1089
2.24
22.17
2.0
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
848
7021
2.46
22.17
5.1
4.9
mmol/l
1.4
1.4
0.13
734
6253
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
290
1651
2.07
22.15
3.2
2.3
mmol/l
2.5
2.5
1.99
251
1405
(3023520) Reticulocytes [#/volume] in Blood
180
847
2.38
22.06
2.9
2.2
e9/l
66.6
66.5
0.01
121
658
(3022145) Colonoscopy Study observation
149
643
2.55
22.03
1.3
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
706
5450
2.03
22.01
3.9
3.7
pmol/l
15.2
15.2
0.09
606
4776
(3052851) Hemolysis interference index of Serum or Plasma
78
242
3.41
20.91
2.8
3.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
117
460
2.75
20.81
1.8
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
423
2798
1.89
20.57
4.2
3.2
mmol/l
6.3
7.2
5.05
347
2302
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
19
14
13.82
20.26
2.9
2.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
139
607
2.50
19.96
1.9
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
80
261
3.25
19.78
1.6
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
174
847
2.28
19.56
4.7
3.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
302
1820
1.95
19.20
4.5
4.3
ng/l
123.4
439.6
3.26
277
1599
(3000494) Fungus identified in Specimen by Culture
165
792
2.30
19.14
1.8
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
238
1325
2.05
18.93
2.3
1.8
s
30.3
30.4
0.03
233
1273
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
110
443
2.67
18.62
1.9
1.6
g/l
1.4
1.5
0.92
96
375
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
491
3482
1.81
18.48
5.9
4.1
ug/l
2.6
2.3
0.67
429
3065
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
815
6796
2.13
18.32
4.6
4.3
mmol/l
1.3
1.2
0.08
693
5980
(3012516) Albumin [Mass/volume] in Urine
411
2777
1.82
18.03
4.4
3.3
mg/l
186.9
186.3
0.00
288
1792
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
104
416
2.68
17.82
5.2
3.6
mmol/l
23.5
24.1
1.06
97
368
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
130
580
2.43
17.75
1.8
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
450
3142
1.79
17.55
3.6
3.2
ng/l
2718.1
1975.2
1.77
397
2718
(3014111) Lactate [Moles/volume] in Serum or Plasma
154
744
2.27
17.51
6.8
5.4
mmol/l
1.4
1.5
0.82
142
716
(3020682) Albumin/Creatinine [Ratio] in Urine
428
2952
1.79
17.34
5.2
4.0
mg/mmol
12.6
8.0
1.42
290
1899
(3000991) Gas panel - Venous blood
148
711
2.27
17.04
9.0
6.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
306
1917
1.86
16.92
3.6
2.8
ug/l
0.8
0.8
0.11
239
1384
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
28
45
6.37
16.81
1.6
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
151
737
2.24
16.72
4.4
2.2
umol/l
11.1
9.5
0.18
138
631
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
105
437
2.57
16.59
6.7
6.7
mmol/l
24.7
24.8
0.10
105
432
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
20
9.67
16.15
2.2
1.6
e6/l
585.4
1077.8
—
5
9
(3026008) Bacteria identified in Urine by Culture
398
2738
1.76
15.90
4.1
3.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
66
220
3.14
15.74
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
66
220
3.14
15.74
1.5
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
315
2029
1.81
15.71
4.2
2.4
u/l
38.2
36.8
0.08
288
1919
(3005719) IgG [Mass/volume] in Serum or Plasma
106
455
2.49
15.69
3.9
1.9
g/l
10.0
10.9
1.44
100
413
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
52
152
3.56
15.27
2.6
1.5
u/ml
32.7
58.8
0.24
43
121
(40768800) Prostate Pathology biopsy report
29
54
5.50
15.02
1.2
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
191
1062
1.99
14.91
7.6
5.7
mmol/l
104.3
104.2
0.08
185
1031
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
244
1484
1.86
14.50
1.7
1.6
mg/l
1.4
1.4
0.25
187
1149
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
298
1928
1.78
14.43
1.7
1.6
mmol/l
1.3
1.3
0.38
250
1572
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
528
4028
1.67
13.73
3.8
2.9
u/l
63.3
52.0
1.56
474
3595
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
22
8.31
13.66
1.7
3.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
18
22
8.31
13.66
1.6
1.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
98
433
2.40
13.59
8.1
7.4
mmol/l
24.5
24.3
0.35
88
396
(3004588) Protein electrophoresis panel - Serum or Plasma
133
671
2.13
13.44
2.9
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
18
7
26.14
13.39
1.2
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
145
763
2.06
13.10
3.0
1.6
g/l
63.7
66.5
3.79
131
671
(3007164) IgA [Mass/volume] in Serum or Plasma
190
1107
1.89
12.76
1.7
1.3
g/l
2.8
2.9
0.09
90
601
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
36
93
3.98
12.62
1.6
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
77
316
2.56
12.50
2.6
1.5
g/l
0.7
0.6
0.20
67
263
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
48
154
3.22
12.21
2.1
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
26
54
4.92
11.95
1.2
1.1
u/l
56.0
53.7
0.05
20
34
(3011412) CD3 cells [#/volume] in Blood
19
29
6.66
11.95
2.3
2.4
e9/l
1.2
0.8
0.84
12
15
(3045142) Bone marrow Pathology biopsy report
28
62
4.62
11.94
1.4
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
307
2097
1.67
11.81
2.0
1.8
nmol/l
1157.3
1160.5
0.02
222
1542
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
69
276
2.61
11.80
2.3
1.4
g/l
0.0
0.1
0.09
62
251
(3021601) Nitrite [Presence] in Urine by Test strip
486
3734
1.59
11.50
6.0
5.3
estimate
0.0
0.0
0.00
109
637
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
390
2846
1.61
11.45
4.9
4.0
%
23.0
24.7
1.24
206
1467
(3035350) Ketones [Presence] in Urine by Test strip
487
3747
1.59
11.43
4.5
3.9
estimate
0.0
0.0
0.00
102
652
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
34
91
3.83
11.37
9.5
6.8
mg/l
12.8
12.6
0.08
29
85
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
65
260
2.61
11.12
2.3
1.4
g/l
0.0
0.0
0.00
58
236
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
64
255
2.61
11.04
2.3
1.4
g/l
0.0
0.0
0.00
57
234
(40768795) Lymph node Pathology biopsy report
15
19
8.00
11.03
1.1
1.0
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
16
22
7.38
11.01
1.3
2.9
%
12.4
15.5
—
7
11
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
38
113
3.46
10.91
2.2
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
48
165
3.01
10.90
2.2
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
51
182
2.90
10.84
1.7
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
488
3789
1.57
10.79
4.6
3.9
estimate
0.0
0.0
0.00
106
632
(3009445) Proteinase 3 Ab [Units/volume] in Serum
77
339
2.38
10.76
2.3
1.5
u/ml
20.5
18.0
—
5
9
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
47
163
2.98
10.51
3.0
2.0
g/l
3.5
3.5
0.12
40
151
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
68
287
2.47
10.42
2.9
3.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
80
366
2.29
10.25
2.3
1.3
g/l
1.3
1.1
0.32
70
332
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
32
89
3.68
10.15
1.4
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
371
2740
1.57
10.01
2.5
2.2
u/l
162.1
262.3
1.61
339
2543
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
54
208
2.69
9.97
2.0
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
20
39
5.21
9.86
1.4
1.1
—
—
—
0
0
(3036489) Thrombin time
54
210
2.66
9.79
2.1
1.7
s
24.1
21.4
0.65
48
187
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
54
210
2.66
9.79
2.0
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
69
302
2.38
9.78
3.4
1.5
mg/l
51.3
36.6
0.47
54
244
(3024891) Influenza virus A+B Ag [Presence] in Specimen
49
182
2.78
9.70
1.4
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
38
122
3.20
9.69
1.7
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
162
976
1.79
9.60
1.3
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
43
150
2.95
9.54
1.5
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
163
986
1.78
9.52
2.9
3.1
ng/l
333.0
265.3
0.78
152
915
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
98
3.45
9.52
1.8
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
680
5779
1.57
9.44
36.8
21.2
g/l
329.6
331.4
5.67
675
5725
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
39
130
3.08
9.36
1.4
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
110
591
1.97
9.30
7.4
3.8
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
68
303
2.34
9.26
3.4
1.5
mg/l
55.4
51.0
0.21
53
243
(3051611) Lipemic interference index of Serum or Plasma
28
77
3.71
9.04
2.9
3.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
15
24
6.33
9.01
1.2
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
66
294
2.33
9.00
3.5
1.5
ratio
2.8
1.3
—
5
24
(3037522) Nuclear Ab [Titer] in Serum
139
815
1.82
8.99
1.4
1.3
titre
518.3
610.7
0.17
23
199
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
32
97
3.38
8.95
1.8
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
354
2.21
8.93
2.7
1.5
g/l
3.4
3.1
1.33
63
273
(40760888) Immunoglobulin light chains.free panel - Serum
54
222
2.52
8.77
3.7
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
118
664
1.88
8.68
6.6
2.7
mmol/l
1.2
1.2
1.10
99
551
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
32
99
3.31
8.68
3.9
4.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
196
1285
1.66
8.49
1.3
1.2
u/ml
5.2
1.9
0.35
30
319
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
34
112
3.11
8.34
4.8
2.8
%
58.2
60.5
0.40
34
112
(3030905) Polymorphonuclear cells [#/volume] in Blood
33
107
3.16
8.31
4.0
2.6
e9/l
4.2
4.8
0.68
33
107
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
385
2.11
8.31
2.7
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
385
2.11
8.31
2.7
1.4
g/l
3.7
3.9
0.47
62
270
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
385
2.11
8.31
2.7
1.4
g/l
7.6
7.6
0.05
65
275
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
66
306
2.24
8.22
2.3
1.4
g/l
36.0
37.0
0.68
58
248
(3017446) Testosterone [Moles/volume] in Serum or Plasma
73
353
2.15
8.20
2.1
2.2
nmol/l
14.7
14.7
0.00
61
302
(3048929) Epstein Barr virus Ab [Presence] in Serum
32
103
3.18
8.16
1.3
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
214
1453
1.60
8.01
39.0
33.0
inr
1.6
1.5
0.12
18
195
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
79
3.49
7.99
1.7
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
45
178
2.60
7.93
5.8
4.9
mmol/l
2.6
3.1
0.41
31
119
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
89
470
1.98
7.90
2.5
2.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
28
85
3.36
7.84
2.5
2.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
73
364
2.09
7.58
2.7
1.4
g/l
10.0
10.6
0.85
66
301
(3002032) Base excess in Venous blood by calculation
145
905
1.71
7.52
5.6
3.2
mmol/l
1.0
2.0
2.38
123
716
(3017181) Myelocytes/100 leukocytes in Blood
101
568
1.87
7.44
5.9
3.3
%
0.8
0.8
0.11
44
131
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
60
279
2.22
7.43
1.3
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
37
4.66
7.42
1.2
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
59
273
2.23
7.40
5.5
2.4
g/l
0.2
0.3
0.35
29
84
(3037692) Legionella sp identified in Specimen by Organism specific culture
13
22
5.97
7.39
1.8
1.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
316
2374
1.49
7.38
3.1
2.2
u/l
66.5
59.4
0.54
280
2157
(3002179) Metamyelocytes/100 leukocytes in Blood
93
511
1.91
7.36
5.1
3.3
%
0.5
0.6
0.02
31
98
(3036481) Cortisol [Moles/volume] in Serum or Plasma
105
603
1.83
7.24
3.4
1.7
nmol/l
360.3
367.2
0.12
98
526
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
30
5.06
7.20
1.2
1.1
—
—
—
0
0
(3010421) pH of Blood
50
218
2.36
7.20
5.9
4.5
ph
7.4
7.4
1.04
45
174
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
106
612
1.82
7.18
1.3
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
10
13
7.76
7.13
15.5
8.3
mmol/l
5.1
6.0
—
10
13
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
95
532
1.87
7.10
8.7
7.2
%
0.6
0.7
3.17
95
526
(3021440) Promyelocytes/100 leukocytes in Blood
97
547
1.86
7.09
6.1
3.4
%
0.1
0.1
0.31
41
122
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
31
4.90
6.94
2.4
2.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
68
342
2.06
6.92
2.3
2.2
ug/l
368.8
514.8
0.40
61
318
(40760892) CBC W Ordered Manual Differential panel - Blood
195
1338
1.57
6.90
6.7
4.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
11
17
6.53
6.78
1.8
2.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
67
341
2.03
6.61
1.4
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
25
79
3.22
6.60
3.4
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
21
5.77
6.60
1.2
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
255
1871
1.49
6.58
3.9
3.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
30
106
2.89
6.57
1.9
1.9
%
89.0
89.3
0.06
30
106
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
158
1045
1.61
6.51
7.2
5.7
kpa
5.0
5.0
0.45
145
994
(3027801) Oxygen [Partial pressure] in Arterial blood
158
1045
1.61
6.51
7.1
5.7
kpa
11.6
11.2
0.39
145
991
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
15
33
4.60
6.47
2.5
1.4
g/l
0.9
0.9
0.08
15
33
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
30
107
2.86
6.46
1.3
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
60
3.55
6.46
3.2
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
45
197
2.35
6.44
2.2
2.6
—
—
—
0
0
(3012544) pH of Venous blood
145
942
1.63
6.42
5.6
3.2
—
7.4
—
0
6
(3021447) Carbon dioxide [Partial pressure] in Venous blood
141
910
1.64
6.41
5.7
3.2
kpa
5.7
5.8
0.79
135
882
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
7
14.41
6.40
5.1
5.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
42
180
2.39
6.31
2.8
2.5
%
15.4
16.0
0.48
21
91
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
47
3.88
6.28
1.2
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
46
206
2.29
6.26
1.5
1.6
e6/l
23603.8
16113.8
0.35
33
144
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
25
82
3.10
6.22
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
41
175
2.40
6.21
4.9
4.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
25
83
3.06
6.10
1.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
29
106
2.79
5.99
1.8
1.3
—
—
—
0
0
(44790047)
24
79
3.09
5.95
1.6
1.3
—
—
—
0
0
(44790048)
24
79
3.09
5.95
1.6
1.3
—
—
—
0
0
(44790049)
24
79
3.09
5.95
1.6
1.3
—
—
—
0
0
(44806118)
24
79
3.09
5.95
1.6
1.3
—
—
—
0
0
(3000492) Spirometry study
85
487
1.82
5.92
1.5
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
43
193
2.28
5.84
1.3
1.4
ug/g
258.9
281.4
0.31
27
117
(3051651) Icteric interference index of Serum or Plasma
15
36
4.22
5.83
2.5
2.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
17
45
3.83
5.83
2.1
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
17
45
3.83
5.83
2.1
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
21
65
3.28
5.75
3.2
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
154
1045
1.56
5.67
7.3
5.7
mmol/l
0.6
1.2
1.14
122
790
(3013512) EKG study
327
2577
1.40
5.61
5.0
4.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
77
3.03
5.55
1.3
1.2
u/ml
255.9
277.0
0.14
17
42
(3028433) Virus identified in Specimen by Culture
11
21
5.29
5.53
2.1
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
21
5.29
5.53
2.0
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
29
4.53
5.52
1.2
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
94
2.81
5.50
1.9
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
64
344
1.92
5.45
2.6
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
24
84
2.90
5.38
1.2
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
87
519
1.74
5.31
6.1
3.4
%
0.0
0.8
0.49
38
106
(21494814) CD8 cells/100 lymphocytes in Specimen
9
8
11.34
5.29
1.2
4.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
8
11.34
5.29
5.0
6.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
36
158
2.33
5.17
2.0
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
31
127
2.49
5.16
1.5
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
426
3543
1.36
5.13
4.7
4.4
ng/l
38.2
72.9
1.64
347
2777
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
87
2.80
5.07
1.3
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
79
466
1.76
5.02
1.2
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
22
78
2.86
4.84
1.3
1.5
—
—
—
0
0
(4281824)
12
28
4.33
4.83
1.2
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
86
526
1.70
4.81
5.4
3.6
mmol/l
1.0
1.9
1.27
64
375
(3016650) Hepatitis A virus Ab [Presence] in Serum
23
85
2.75
4.70
1.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
43
3.53
4.62
1.9
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
7
5
14.08
4.58
1.3
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
34
3.86
4.54
2.0
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
34
3.86
4.54
2.0
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
100
647
1.61
4.51
2.6
1.9
ug/g
233.9
170.1
0.62
72
487
(3002173) Hemoglobin [Mass/volume] in Arterial blood
124
846
1.53
4.45
8.1
6.2
g/l
115.5
121.3
2.27
119
820
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
64
369
1.79
4.42
3.1
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
88
555
1.64
4.40
5.5
3.7
kpa
5.0
5.2
1.34
83
502
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
13
35
3.75
4.37
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
13
35
3.75
4.37
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
83
517
1.66
4.35
1.5
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
16
50
3.24
4.35
1.4
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
79
486
1.68
4.34
1.7
1.6
%
1.6
1.7
0.22
67
395
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
95
613
1.61
4.34
3.6
2.5
ml/min/173m2
51.4
59.0
1.44
49
263
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
6
11.74
4.28
1.3
5.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
52
284
1.88
4.27
1.4
2.0
u/l
42.5
38.7
0.50
44
232
(3009343) pH of Capillary blood
86
544
1.64
4.25
5.5
3.7
ph
7.4
7.4
0.21
16
65
(1002224) Polysomnography panel
32
147
2.22
4.18
1.0
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
134
942
1.49
4.17
7.6
5.9
%
95.4
94.9
0.45
127
903
(3024354) Oxygen [Partial pressure] in Venous blood
113
767
1.53
4.15
4.1
2.6
kpa
5.0
4.4
1.14
107
740
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
63
370
1.75
4.10
2.1
1.7
ug/l
1.3
2.0
0.57
51
312
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
16
52
3.11
4.09
1.7
1.2
u/l
14.6
15.5
0.15
16
47
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
54
303
1.83
4.09
3.1
2.8
pmol/l
4.2
4.4
0.57
46
252
(3024471) HLA-A [Type]
8
10
8.05
4.06
1.4
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
37
3.55
4.06
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
126
2.26
3.86
7.4
2.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
34
166
2.09
3.84
1.4
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
44
3.21
3.78
1.1
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
13
39
3.36
3.77
1.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
5
12.06
3.76
6.7
1.4
—
—
—
0
0
(3019225) pH of Specimen
122
860
1.48
3.75
7.9
3.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
19
73
2.63
3.65
10.1
2.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
69
430
1.65
3.65
1.3
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
56
2.89
3.64
2.9
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
56
2.89
3.64
2.9
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
56
2.89
3.64
2.9
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
9
7.82
3.56
1.6
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
8
13
6.19
3.50
2.3
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
13
6.19
3.50
1.3
1.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
21
88
2.42
3.41
2.5
1.6
u/ml
34.1
60.9
0.48
21
79
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
18
5.04
3.37
4.1
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
17
65
2.64
3.31
2.3
2.0
ug/min
101.6
135.3
—
7
19
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
44
249
1.80
3.29
1.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
29
142
2.07
3.29
1.4
1.2
u/l
22.3
21.3
0.09
23
125
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
7
8.61
3.26
1.7
1.0
u/ml
15.7
17.6
—
6
7
(3012441) Differential panel - Pleural fluid
21
90
2.36
3.26
1.5
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
60
2.69
3.24
1.9
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
39
214
1.86
3.22
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
22
97
2.30
3.21
1.6
1.6
e6/l
79981.9
90944.4
0.04
13
56
(3004775) Volume in Urine collected for unspecified duration
21
91
2.34
3.19
3.8
2.3
ml
822.0
644.9
0.90
16
59
(3022313) Gas panel - Capillary blood
63
398
1.62
3.19
6.0
3.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
68
439
1.59
3.15
9.8
8.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
39
216
1.84
3.13
1.1
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
36
196
1.87
3.06
1.6
1.6
iu/ml
0.6
0.3
—
5
51
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
8
7.54
3.06
1.2
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
38
212
1.82
3.00
1.1
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
31
162
1.94
2.97
1.2
1.4
mmol/l
58.7
62.4
0.24
24
126
(4306422)
15
57
2.66
2.97
1.4
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
41
236
1.77
2.93
1.2
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
23
108
2.16
2.92
1.6
1.5
e6/l
1432.2
1611.3
0.13
15
76
(3027456) Digoxin [Moles/volume] in Serum or Plasma
47
282
1.70
2.91
3.0
3.4
nmol/l
0.8
0.8
0.39
35
221
(3047189) Immunofixation for 24 hour Urine
10
30
3.36
2.91
2.3
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
22
4.12
2.88
7.7
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
27
136
2.01
2.87
1.4
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
37
208
1.81
2.86
2.4
2.3
g/l
121.7
131.5
1.46
28
150
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
80
550
1.49
2.82
1.5
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
47
2.79
2.82
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
47
2.79
2.82
1.2
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
18
4.47
2.80
1.4
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
18
4.47
2.80
4.4
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
18
4.47
2.80
4.4
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
42
2.88
2.75
1.1
1.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
29
153
1.92
2.73
2.8
2.2
%
61.2
62.3
0.08
29
153
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
10
6.03
2.70
1.2
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
92
2.20
2.68
1.6
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
43
260
1.68
2.61
4.2
2.4
ug/min
46.9
65.5
0.55
27
155
(3033799) Differential panel - Peritoneal fluid
8
20
4.02
2.57
2.1
1.8
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
7
7.17
2.55
2.4
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
32
179
1.81
2.54
1.1
1.1
—
602.0
—
0
5
(3035637) Corticotropin [Mass/volume] in Plasma
12
45
2.69
2.45
2.2
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
57
2.48
2.45
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
51
2.57
2.45
1.3
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
30
167
1.82
2.43
3.1
3.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
52
339
1.56
2.37
6.8
4.0
mmol/l
24.0
24.8
0.99
47
302
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
52
2.52
2.36
1.4
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
28
3.23
2.31
4.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
28
3.23
2.31
4.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
28
3.23
2.31
4.0
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
28
3.23
2.31
4.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
59
2.39
2.30
1.1
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
13
4.64
2.27
1.2
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
36
217
1.68
2.25
1.6
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
198
1634
1.26
2.24
1.3
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
9
5.58
2.21
5.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
63
438
1.47
2.16
3.0
2.9
e9/l
4.2
4.3
0.07
43
284
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
135
1066
1.31
2.15
1.3
1.3
iu/ml
37.6
41.7
0.09
41
343
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
25
3.22
2.09
1.0
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
16
75
2.15
2.09
1.3
1.4
pmol/l
228.6
252.7
0.21
16
52
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
10
5.02
2.07
1.0
3.9
%
188.4
164.3
—
5
10
(3008536) Aspergillus sp Ab [Presence] in Serum
5
10
5.02
2.07
2.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
10
5.02
2.07
1.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
40
254
1.60
2.06
1.1
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
27
154
1.77
2.05
1.7
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
132
1.84
2.05
1.4
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
15
4.02
2.04
1.5
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
12
50
2.42
2.03
1.0
1.0
mg/l
307.5
290.3
0.26
12
44
(3041096) Erythrocytes [Presence] in Urine by Automated
225
1910
1.23
1.97
5.0
3.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
7
21
3.35
1.96
5.3
1.1
—
38.2
—
0
5
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
87
1.97
1.80
2.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
87
1.97
1.80
2.3
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
35
2.59
1.80
1.3
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
35
2.59
1.80
1.2
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
67
2.11
1.76
1.2
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
63
457
1.40
1.76
4.1
2.6
e6/l
0.4
0.3
0.16
63
447
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
88
1.95
1.75
2.2
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
48
2.31
1.71
1.7
1.2
ug/l
16.6
15.5
0.18
11
48
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
89
1.93
1.70
2.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
89
1.93
1.70
2.3
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
89
1.93
1.70
2.3
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
15
75
2.02
1.70
1.3
1.3
mmol/l
5.8
7.7
1.31
15
69
(3017704) Immunofixation for Urine
12
55
2.20
1.68
1.6
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
17
90
1.90
1.66
1.7
1.6
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
6
20
3.01
1.58
1.7
1.2
g/l
12.3
13.9
—
6
12
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
20
3.01
1.58
1.0
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
20
3.01
1.58
1.5
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
19
107
1.79
1.55
1.2
1.4
%
60.2
70.7
0.41
12
70
(4034850)
16
282
0.56
1.52
19.6
12.4
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
7
27
2.60
1.51
1.9
2.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
27
2.60
1.51
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
120
980
1.26
1.51
2.2
2.6
ug/l
6.0
7.4
0.45
100
831
(3042631) Mycobacterium sp identified in Specimen
18
101
1.80
1.49
3.3
2.7
—
—
—
0
0
(4010399)
75
579
1.32
1.46
1.5
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
38
2.38
1.46
2.6
2.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
236
2071
1.18
1.45
1.8
1.8
pmol/l
461.0
17312773.3
1.30
179
1652
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
39
2.32
1.43
2.6
3.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
46
2.19
1.40
1.2
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
26
167
1.57
1.35
1.8
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
98
1.75
1.31
1.5
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
29
193
1.52
1.30
1.4
1.4
g/l
1.1
1.1
0.04
29
183
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
24
2.51
1.30
2.5
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
57
432
1.34
1.28
2.7
2.5
—
15.0
—
0
7
(3014271) Vancomycin [Susceptibility]
12
62
1.95
1.28
3.8
3.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
48
2.09
1.28
2.7
2.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
154
1790
0.83
1.28
4.9
4.4
kg/l
1.0
1.0
0.21
20
297
(3044242) Glucose [Moles/volume] in Arterial blood
12
63
1.92
1.23
1.4
1.6
—
—
—
0
0
(4062490)
10
49
2.05
1.22
1.3
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
26
2.32
1.19
1.3
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
72
1.82
1.15
1.2
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
209
1853
1.16
1.13
3.7
3.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
43
319
1.36
1.13
1.9
2.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
14
81
1.74
1.09
1.1
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
21
2.39
1.09
2.0
2.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
32
2.20
1.08
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
33
2.13
1.05
1.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
33
2.13
1.05
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
22
2.28
1.03
1.0
1.1
miu/ml
3206.4
1780.3
—
5
22
(3032057) Clostridioides difficile [Presence] in Stool
5
22
2.28
1.03
1.4
2.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
22
2.28
1.03
1.8
1.3
u/l
48.8
28.1
—
5
16
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
34
2.07
1.03
3.4
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
34
2.07
1.03
3.4
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
19
124
1.54
0.97
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
78
648
1.22
0.91
4.7
4.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
37
483
0.76
0.90
6.7
3.4
%
48.1
47.0
0.09
37
477
(3029634) Reagin Ab [Titer] in Serum by VDRL
12
71
1.70
0.89
3.0
1.5
—
—
—
0
0
(4268621)
8
42
1.91
0.88
2.1
2.0
—
—
—
0
0
(3004451) EKG impression Narrative
8
43
1.87
0.87
1.5
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
30
2.01
0.87
1.0
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
39
502
0.77
0.86
3.4
3.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
19
274
0.69
0.85
3.9
4.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
17
113
1.51
0.82
3.2
2.5
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
32
1.88
0.82
1.7
2.0
nmol/l
14.2
17.4
—
6
24
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
33
1.82
0.79
2.7
1.9
u/ml
3574.8
1389.0
—
6
33
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
151
0.59
0.79
2.6
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
228
2091
1.12
0.76
6.0
4.2
estimate
0.0
0.0
0.00
105
611
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
24
2.09
0.74
5.0
2.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
26
1.93
0.70
1.4
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
41
1.71
0.70
1.1
1.0
—
—
—
0
0
(4094501)
25
187
1.35
0.68
1.2
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
27
1.86
0.68
1.6
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
27
1.86
0.68
1.6
2.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
27
1.86
0.68
1.0
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
38
303
1.26
0.67
1.1
1.2
iu/ml
203.9
105.8
—
7
112
(3017569) Oxygen content in Arterial blood
10
62
1.62
0.65
1.9
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
62
1.62
0.65
1.4
1.2
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
5
29
1.73
0.64
1.2
1.2
%
67.4
61.8
—
5
24
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
12
79
1.53
0.62
1.5
2.0
u/field
2.4
1.8
—
5
26
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
101
0.59
0.62
2.2
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
49
1.64
0.62
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
30
1.67
0.61
1.4
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
20
0.00
0.60
0.0
2.4
—
1.2
—
0
20
(21494755) Public health laboratory ask at order entry panel
10
150
0.66
0.58
1.8
1.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
90
0.55
0.56
5.4
3.2
umol/l
271.0
329.0
—
5
75
(3006653) Thiamine [Moles/volume] in Blood
6
37
1.63
0.55
1.8
1.1
nmol/l
125.0
139.7
—
6
37
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
148
0.67
0.55
1.1
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
23
177
1.31
0.55
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
50
587
0.84
0.53
2.8
3.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
113
1020
1.12
0.52
1.4
1.3
u/ml
26.5
15.6
0.29
25
354
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
126
1.36
0.52
1.6
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
53
457
1.17
0.48
4.5
2.4
%
0.6
0.6
1.06
53
440
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
117
1066
1.11
0.47
5.2
5.1
%
37.2
33.8
2.15
77
686
(3016018) Differential panel - Cerebral spinal fluid
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
69
1.45
0.44
1.3
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
87
1.38
0.42
2.4
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
32
1.57
0.42
1.0
1.9
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
5
32
1.57
0.42
1.0
1.2
u/l
95.4
94.3
—
5
23
(3035285) Chloride [Moles/volume] in Venous blood
10
139
0.72
0.42
6.5
2.2
mmol/l
106.9
105.2
—
10
139
(3041354) Potassium [Moles/volume] in Venous blood
10
139
0.72
0.42
6.5
2.2
mmol/l
4.1
4.1
—
10
139
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
58
1.38
0.41
3.3
2.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
16
0.00
0.41
0.0
1.3
—
103.1
—
0
10
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
16
0.00
0.41
0.0
7.6
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
18
0.00
0.40
0.0
3.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
101
0.69
0.39
3.6
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
97
1.34
0.39
1.5
1.4
—
—
—
0
0
(4015189)
5
35
1.43
0.39
1.2
2.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
133
1.28
0.38
1.2
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
12
89
1.35
0.38
1.5
1.9
pmol/l
201.4
212.9
0.19
12
82
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
68
1.33
0.37
1.2
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
224
0.80
0.37
2.5
1.9
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
135
0.74
0.36
6.5
2.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
42
1.43
0.35
1.5
1.2
—
—
—
0
0
(4024509)
10
73
1.37
0.34
1.9
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
82
749
1.10
0.34
6.1
3.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.33
1.3
1.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
16
128
1.25
0.32
1.4
1.7
iu/l
1.8
4.8
—
6
43
(3001019) Free T4 and TSH panel - Serum or Plasma
12
93
1.29
0.30
1.8
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
19
157
1.21
0.29
1.3
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
19
226
0.84
0.27
4.7
2.9
mmol/l
7.1
7.9
0.80
19
221
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
66
1.21
0.26
1.4
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
72
1.25
0.25
1.3
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
73
1.23
0.25
1.1
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
12
96
1.25
0.24
2.4
1.2
nmol/l
0.9
0.6
0.96
12
89
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
111
1175
0.94
0.24
10.1
7.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
297
2887
1.04
0.22
5.3
4.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
1.9
—
0
10
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
89
1.24
0.21
1.3
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
48
1.25
0.20
1.2
1.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
6
51
1.18
0.19
1.2
1.6
umol/l
13.7
15.7
—
6
42
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
63
1.11
0.17
1.3
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
68
1.18
0.16
1.9
1.8
%
10.8
10.4
—
8
68
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
68
643
1.06
0.16
1.5
1.6
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
6
77
0.78
0.15
1.2
1.2
nmol/l
1.4
1.5
—
6
64
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
17
150
1.14
0.14
1.2
1.1
—
18.2
—
0
11
(3005570) Glucose [Moles/volume] in Urine
8
98
0.81
0.13
1.5
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
178
0.90
0.11
1.6
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
21
192
1.10
0.11
1.5
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
115
0.87
0.10
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
115
1.13
0.10
1.2
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
5
47
1.06
0.09
1.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
17
155
1.10
0.09
1.5
1.7
mg/l
2.7
3.3
—
10
119
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
154
0.91
0.08
1.6
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
68
1.03
0.08
1.1
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
6
71
0.84
0.07
1.3
1.1
—
65.6
—
0
5
(3051593) INR in Capillary blood by Coagulation assay
8
74
1.08
0.07
2.1
12.5
—
—
—
0
0
(3020891) Body temperature
38
398
0.95
0.07
7.3
4.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
27
286
0.94
0.07
6.3
5.1
mmol/l
1.4
1.3
0.16
22
259
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
85
1.06
0.07
2.7
1.2
nmol/l
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
37
355
1.04
0.06
4.3
3.7
mmol/l
1.2
1.5
2.02
37
347
(3043409) Potassium [Moles/volume] in Arterial blood
29
303
0.96
0.05
5.1
4.0
mmol/l
3.9
3.9
0.06
24
279
(4146454)
10
109
0.92
0.04
1.9
2.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
198
0.96
0.02
2.3
2.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
221
1.00
0.00
1.7
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
119
1.01
0.00
1.2
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
14.9
—
0
7
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
93
0.97
0.00
1.1
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
93
0.97
0.00
1.6
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_TRUNK_EXALLC – Carcinoma in situ of skin of trunk
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).